IL-36 Receptor Antagonist with Special Emphasis on IL-38

Author:

Shaik Y.1,Sabatino G.2,Maccauro G.3,Varvara G.4,Murmura G.4,Saggini A.5,Rosati M.6,Conti F.6,Cianchetti E.7,Caraffa A.8,Antinolfi P.8,Pandolfi F.9,Potalivo G.8,Galzio R.10,Conti P.11,Theoharides T.C.12

Affiliation:

1. Department of Medicine, Boston University School of Medicine, Boston, MA, USA

2. Neonatology Division, University of Chieti, Italy

3. Department of Orthopedics, Catholic University of Rome, Italy

4. Dental School, University of Chieti-Pescara, Italy

5. Department of Dermatology, University of Rome Tor Vergata, Rome, Italy

6. Gynecology Division, Pescara Hospital, Pescara, Italy

7. Ortona Hospital, University of Chieti-Pescara, Italy

8. Orthopeadics Division, University of Perugia, Perugia Italy

9. Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy

10. Department of Health Sciences, University of L ‘Aquila, Italy

11. Immunology Division, Department of Experimental and Clinical Sciences, University of Chieti, Italy

12. Department of Pharmacology and Experimental Therapeutics, Biochemistry and Internal Medicine Tufts University School of Medicine, Tufts-New England Medical Center, Boston, MA, USA

Abstract

IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFκB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.

Publisher

SAGE Publications

Subject

Pharmacology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3